跳至主要内容
临床试验/ACTRN12618000013268
ACTRN12618000013268已完成1 期

A single center, randomized, double blind, 3-treatment, 3-period, single-dose, cross over, comparative Phase-1 study to evaluate pharmacokinetics, safety, tolerability, and pharmacodynamics (PK/PD) of Stelis Teriparatide [rh-PTH (1-34)] with Forsteo® and Forteo® (teriparatide, Eli Lilly) in healthy volunteers following subcutaneous single dose administration of 20 µg Teriparatide

Stelis Biopharma Private Limited0 个研究点目标入组 78 人开始时间: 2018年1月10日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Stelis Biopharma Private Limited

相似试验

已完成
不适用
A single center, randomized, double-blind, 3-arm parallel Phase I study to assess pharmacokinetics, safety and tolerability of MYL-1402O solution for intravenous infusion after 90 minute intravenous infusion at one dose level (equivalent weight-adjusted dose (1 mg/kg) compared to the EU and US marketed drug product (Avastin®) in healthy male volunteers.10035227Cancer
NL-OMON42579Mylan Pharmaceuticals111
已完成
1 期
A phase 1 clinical trial to evaluate the safety, pharmacokinetics/pharmacodynamics, and immunogenicity of single and multiple ascending subcutaneous doses of RS2102 in healthy adult subjectsInflammatory and Immune System - Autoimmune diseasesSystemic lupus erythematosus
ACTRN12621001161819Atridia Pty Ltd56
招募中
1 期
Part 1 and Part 3:A Study to evaluate the safety,Tolerability,Pharmacokinetics of AC-201
ACTRN12623000375651Accro Bioscience (Australia) Pty Ltd82
已完成
不适用
Single center, randomized, double-blind, 3-period, 3 treatments, 3 way crossover pharmacokinetics (PK)/pharmacodynamics (PD) trial to assess PK, PD, safety and tolerability of MYL-1401H after single subcutaneous injection at one dose level (2 mg) comparing to an EU and US marketed drug product (NEULASTA®) in healthy volunteers.Neutropenia.10047954
NL-OMON40799Mylan GmbH216
暂停
不适用
A single center, randomized, double-blind, placebo-controlled, single and multiple-dose study of DEB025 (alisporivir) in healthy Chinese and Caucasian subjectsFactors influencing health status and contact with health servisces
KCT0000363Seoul National University Hospital36